Home / Markets / Industries / Health Care
Monday, October 06, 2008
Eli Lilly to Acquire ImClone for More Than $6B
FOXBusiness
Eli Lily (LLY) the Indianaoplis-based drugmaker, will purchase ImClone Systems (IMCL) for more than $6 billion. This deal would expand Eli Lilly’s arm of cancer treatment therapies.
WATCH: Eli Lilly CEO on Buying ImClone
Eli Lily plans to pay $70 per share for ImClone, making the deal worth approximately $6.5 billion. ImClone, which is based in New York, had turned down buyout offers from Bristol Myers Squibb (BMY) of $60 and $62. Bristol Myers Squibb previously partnered with ImClone for marketing the caner drug Erbitux.
Carl Icahn, billionaire investor and ImClone chairman, owns 14% of ImClone and has agreed to vote in favor of the Eli Lilly takeover.
Fox Business Video
-
-
The Business of Sports
-
Nov 7, 2009
FOXBusiness.com LIVE
-
-
-
Jim Caviezel: Hollywood and th...
-
Nov 7, 2009
Actor in life in film
-
-
-
Ticker Tape Parade Invades Downtown
-
Nov 7, 2009
Yankees celebrate 27th World Series win
-
-
-
Cavuto Business Report 11-06-09
-
Nov 7, 2009
Business Report: Cavuto
-
-
-
Pro Poker Player: $2M in 2 Months
-
Nov 7, 2009
Pro Poker player on growing success of sport
-
